News + Filings Holdings
|
VANGUARD GROUP INC
> YMAB
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Y-mAbs Therapeutics, Inc. | YMAB | 2,227,009 | 306,588 | 15,121,392,000 | 15,093,699,000 | $6,790.00 |
| 09/30/2022 | Y-mAbs Therapeutics, Inc. | YMAB | 1,920,421 | -9,495 | 27,693,000 | -1,507,000 | $14.42 |
| 06/30/2022 | Y-mAbs Therapeutics, Inc. | YMAB | 1,929,916 | 135,406 | 29,200,000 | 7,881,000 | $15.13 |
| 03/31/2022 | Y-mAbs Therapeutics, Inc. | YMAB | 1,794,510 | -22,564 | 21,319,000 | -8,136,000 | $11.88 |
| 12/31/2021 | Y-mAbs Therapeutics, Inc. | YMAB | 1,817,074 | 13,150 | 29,455,000 | -22,030,000 | $16.21 |
| 09/30/2021 | Y-mAbs Therapeutics, Inc. | YMAB | 1,803,924 | 168,669 | 51,485,000 | -3,787,000 | $28.54 |
| 06/30/2021 | Y-mAbs Therapeutics, Inc. | YMAB | 1,635,255 | 154,222 | 55,272,000 | -18,054,000 | $33.80 |
| 12/31/2020 | Y-mAbs Therapeutics, Inc. | YMAB | 1,481,033 | 236,743 | 73,326,000 | 25,557,000 | $49.51 |
| 09/30/2020 | Y-mAbs Therapeutics, Inc. | YMAB | 1,244,290 | 4,626 | 47,769,000 | -5,784,000 | $38.39 |
| 06/30/2020 | Y-mAbs Therapeutics, Inc. | YMAB | 1,239,664 | 158,006 | 53,553,000 | 25,321,000 | $43.20 |
| 03/31/2020 | Y-mAbs Therapeutics, Inc. | YMAB | 1,081,658 | 26,461 | 28,232,000 | -4,743,000 | $26.10 |
| 12/31/2019 | Y-mAbs Therapeutics, Inc. | YMAB | 1,055,197 | 312,215 | 32,975,000 | 13,613,000 | $31.25 |
| 09/30/2019 | Y-mAbs Therapeutics, Inc. | YMAB | 742,982 | 253,400 | 19,362,000 | 8,166,000 | $26.06 |
| 06/30/2019 | Y-mAbs Therapeutics, Inc. | YMAB | 489,582 | 205,021 | 11,196,000 | 3,737,000 | $22.87 |
| 03/31/2019 | Y-mAbs Therapeutics, Inc. | YMAB | 284,561 | 27,296 | 7,459,000 | 2,227,000 | $26.21 |
| 12/31/2018 | Y-mAbs Therapeutics, Inc. | YMAB | 257,265 | 172,165 | 5,232,000 | 2,972,000 | $20.34 |
| 09/30/2018 | Y-mAbs Therapeutics, Inc. | YMAB | 85,100 | 85,100 | 2,260,000 | 2,260,000 | $26.56 |
| << Prev Next >> |
|